Modification of CYP2B6-mediated site of metabolism on Artemisinin molecule as a way to prolong its maximal antimalarial efficacy

被引：0
|
作者：
Tsyrlov, I. [1 ]
Woo, C. S. T. [1 ]
Martin, V. P. [1 ]
Shur, I. N. [2 ]
机构：
[1] XENOTOX Inc, Scarsdale, NY USA
[2] ISI Med, Bronx, NY USA
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2014年 / 21卷
关键词：
D O I：
10.1016/j.ijid.2014.03.784
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
45.044
引用
收藏
页码：174 / 174
页数：1
相关论文
共 25 条
  • [1] In vitro Assessment of the Effects of Silybin on CYP2B6-mediated Metabolism
    Zhang, Wenwen
    Zhang, Yice
    Wen, Chengming
    Jiang, Xuehua
    Wang, Ling
    PLANTA MEDICA, 2023, 89 (13) : 1195 - 1203
  • [2] Insights into CYP2B6-mediated drug–drug interactions
    William D.Hedrich
    Hazem E.Hassan
    Hongbing Wang
    ActaPharmaceuticaSinicaB, 2016, 6 (05) : 413 - 425
  • [3] Insights into CYP2B6-mediated drug-drug interactions
    Hedrich, William D.
    Hassan, Hazem E.
    Wang, Hongbing
    ACTA PHARMACEUTICA SINICA B, 2016, 6 (05) : 413 - 425
  • [4] Efavirenz Induces CYP2B6-Mediated Hydroxylation of Bupropion in Healthy Subjects
    Robertson, Sarah M.
    Maldarelli, Frank
    Natarajan, Ven
    Formentini, Elizabeth
    Alfaro, Raul M.
    Penzak, Scott R.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 49 (05) : 513 - 519
  • [5] Development of two-dimensional template system for the prediction of |CYP2b6-mediated reaction sites
    Koyama, Noriyuki
    Yamazoe, Yasushi
    DRUG METABOLISM REVIEWS, 2011, 43 : 133 - 133
  • [6] Development of Two-dimensional Template System for the Prediction of CYP2B6-mediated Reaction Sites
    Koyama, Noriyuki
    Yamazoe, Yasushi
    DRUG METABOLISM AND PHARMACOKINETICS, 2011, 26 (04) : 309 - 330
  • [7] STRONG INHIBITORY EFFECT OF MONOTERPENOIDS ON CYP2B6-MEDIATED BUPROPION HYDROXYLASE ACTIVITY IN HUMAN LIVER MICROSOMES
    Seo, Kyung-Ah
    Kim, Hyunmi
    Ku, Heiyoung
    Park, Soo-Jin
    Bae, Soo Kyung
    Shin, Jae-Gook
    Liu, Kwang-Hyeon
    DRUG METABOLISM REVIEWS, 2007, 39 : 213 - 213
  • [8] Amenamevir: Studies of Potential CYP2C8-and CYP2B6-Mediated Pharmacokinetic Interactions With Montelukast and Bupropion in Healthy Volunteers
    Dennison, Jeremy
    Puri, Adeep
    Warrington, Steven
    Endo, Takamasa
    Adeloye, Temitope
    Johnston, Atholl
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (08): : 860 - 870
  • [9] Predicting metabolic-site-specific kinetic parameters for CYP2D6-mediated drug metabolism
    Zhang, Jinhua
    Fraczkiewicz, Robert
    Waldman, Marvin
    Clark, Robert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 245
  • [10] CYP2A6 and CYP2B6 genetic variation and its association with nicotine metabolism in South Western Alaska Native people
    Binnington, Matthew J.
    Zhu, Andy Z. X.
    Renner, Caroline C.
    Lanier, Anne P.
    Hatsukami, Dorothy K.
    Benowitz, Neal L.
    Tyndale, Rachel F.
    PHARMACOGENETICS AND GENOMICS, 2012, 22 (06): : 429 - 440
123